Tetrabuthylammonium

Tetrabuthylammonium

SCHEMBL28299909

B.CCCC[N+](CCCC)(CCCC)CCCC.[H+]

nearest known ligand 0.86

Full drug profile on Sugi Atlas →

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ SLC22A1 O15245 4/20 0.86
▸ SLC22A2 O15244 1/20 0.73
▸ ALDH1A1 P00352 1/20 0.65
▸ TP53 P04637 1/20 0.65
▸ CYP3A4 P08684 1/20 0.65
▸ ALOX15 P16050 1/20 0.65
▸ TSHR P16473 1/20 0.65
▸ ALOX12 P18054 1/20 0.65
▸ SMN1; SMN2 Q16637 1/20 0.65
▸ HIF1A Q16665 1/20 0.65
▸ HSD17B10 Q99714 1/20 0.65
▸ DNM1 Q05193 6/20 0.58
▸ HTT P42858 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tetrabuthylammonium SCHEMBL792649 0.96 SLC22A1 (0.92) SLC22A1SLC22A2ALDH1A1TP53CYP3A4
Tetrabuthylammonium SCHEMBL17329435 0.96 SLC22A1 (0.92) SLC22A1SLC22A2ALDH1A1TP53CYP3A4
Tetrabuthylammonium SCHEMBL2580744 0.96 SLC22A1 (0.92) SLC22A1SLC22A2ALDH1A1TP53CYP3A4
Tetrabuthylammonium SCHEMBL8840674 0.96 SLC22A1 (0.92) SLC22A1SLC22A2ALDH1A1TP53CYP3A4
Tetrabuthylammonium SCHEMBL633811 0.96 SLC22A1 (0.92) SLC22A1SLC22A2ALDH1A1TP53CYP3A4
Tetrabuthylammonium SCHEMBL57922 0.96 SLC22A1 (0.92) SLC22A1SLC22A2ALDH1A1TP53CYP3A4
Tetrabuthylammonium SCHEMBL4254194 0.93 SLC22A1 (0.86) SLC22A1SLC22A2ALDH1A1TP53CYP3A4
Tetrabuthylammonium SCHEMBL3635739 0.93 SLC22A1 (0.86) SLC22A1SLC22A2ALDH1A1TP53CYP3A4
Tetrabuthylammonium SCHEMBL22658214 0.93 SLC22A1 (0.86) SLC22A1SLC22A2ALDH1A1TP53CYP3A4
Tetrabuthylammonium SCHEMBL71524 0.93 SLC22A1 (0.86) SLC22A1SLC22A2ALDH1A1TP53CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104884465-B Methods and compositions for treating multiple sclerosis and related disorders 乌第有限合伙公司 2019-06-14 — — CN disclosed
Send feedback